Lincoln, MA, United States of America

Alexander J Nichols

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Mythic Therapeutics, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander J Nichols. Retrieved from https://idiyas.com/inventor/alexander-j-nichols-65m5etg3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alexander J Nichols: Innovator in Antibody-Drug Conjugates

Introduction

Alexander J Nichols is a prominent inventor based in Lincoln, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work has the potential to impact cancer treatment and therapeutic applications.

Latest Patents

Nichols holds a patent for "Anti-cMet antibody-drug conjugates and uses thereof." This patent provides detailed information about antibodies and their various applications in medical treatments. His work in this area showcases his commitment to advancing healthcare solutions.

Career Highlights

Nichols is currently associated with Mythic Therapeutics, Inc., where he continues to push the boundaries of scientific research and innovation. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking projects.

Collaborations

Nichols has worked alongside notable colleagues such as Brian P Fiske and Nimish Gera. These collaborations have fostered a dynamic environment for innovation and have led to the development of new therapeutic strategies.

Conclusion

Alexander J Nichols is a key figure in the field of biotechnology, with a focus on antibody-drug conjugates. His contributions and collaborations are paving the way for advancements in cancer treatment and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…